Effect of Montelukast on the Symptom Severity Score of Allergic Rhinitis

作者
Muhammad Shaheryar Ahmed Rajput,Asif Ali Arain,Arsalan Ahmed Rajput,Mohammad Adeel,Shehzad Ghaffar,Anwar Suahil
出处
期刊:Cureus [Cureus, Inc.]
卷期号:12 (3): e7403-e7403 被引量:7
标识
DOI:10.7759/cureus.7403
摘要

Introduction Rhinitis is a common respiratory disorder that can be broadly defined as an inflammation of nasal mucosa. Allergic rhinitis is the most common form of chronic rhinitis characterized by one or more symptoms including sneezing, nasal itching, nasal congestion, postnasal drip, and rhinorrhea. Montelukast is an antagonist to the leukotriene receptor. It is non-sedating, dosed once daily, and has a safety profile similar in adults and children, with approval down to six months of age. The purpose of the study was to see the improvement in the severity of symptoms of the patients with allergic rhinitis treated with montelukast. Methods The symptom severity score for allergic rhinitis was calculated by asking the patient to evaluate the severity of individual symptoms (sneezing, nasal congestion, rhinorrhea, and postnasal drip) against the 4-point scoring scale over the last 24 hours. After explaining the scoring system to the patient, a proforma was filled before starting the treatment. A dose of 10 mg of montelukast once daily was prescribed. On the follow-up visit after four weeks of therapy, compliance was ensured and then the symptom severity score was recorded again on the proforma. The total nasal symptom severity score (TNSSS) was calculated as a sum of all four nasal symptoms. Pre- and post-treatment mean of TNSSS was compared using a t-test. P-value of less than 0.05 was considered significant. Results A total of 140 patients were included in the study. The mean age was 30 years. The minimum age was 15 years and the maximum age was 45 years. There were 93 males and 47 females. The difference between pre- and post-mean values of TNSSS was 5.82. Both pre- and post-mean of TNSSS were compared using the t-test, and P-value was significant, i.e., <0.005. Conclusions The common symptoms of allergic rhinitis evaluated in the study showed improvement in response to the treatment with montelukast. The improvement in symptom severity score was maximum in sneezing and least in rhinorrhea. In light of recent developments on neuropsychiatric adverse effects and FDA warnings, caution needs to be exercised to reserve the use of montelukast for the selected patients.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
DOC_XIONG完成签到,获得积分0
刚刚
科研小白完成签到 ,获得积分10
刚刚
饱满语风完成签到 ,获得积分10
刚刚
赤练仙子发布了新的文献求助10
1秒前
水煮电吹风的应助被SamYang采纳,获得10
1秒前
程娇完成签到,获得积分10
1秒前
1秒前
1秒前
科研通AI2S的应助被能干小蘑菇采纳,获得10
1秒前
智慧大狗发布了新的文献求助10
1秒前
2秒前
Yonaxus完成签到 ,获得积分10
3秒前
宋晓静完成签到,获得积分10
3秒前
年轻的纲完成签到 ,获得积分10
3秒前
mask完成签到,获得积分10
3秒前
serven完成签到,获得积分10
3秒前
小蘑菇的应助被怕黑的缘分采纳,获得10
3秒前
研友_ngkEgn完成签到,获得积分10
4秒前
ww完成签到 ,获得积分10
5秒前
Blue完成签到 ,获得积分10
5秒前
lzx完成签到,获得积分10
5秒前
yu发布了新的文献求助30
5秒前
asdfsdafg发布了新的文献求助10
5秒前
Krystal完成签到,获得积分10
6秒前
Peng小糕完成签到,获得积分10
6秒前
xxk发布了新的文献求助10
6秒前
开心秋天完成签到,获得积分10
6秒前
瓜瓜发布了新的文献求助10
6秒前
6秒前
英吉利25发布了新的文献求助10
6秒前
紧张的幻露完成签到 ,获得积分10
6秒前
LV完成签到,获得积分10
6秒前
6秒前
昱鱼七seven完成签到,获得积分10
7秒前
可达鸭发布了新的文献求助10
7秒前
淡然凤完成签到,获得积分10
7秒前
whhhhhh发布了新的文献求助10
7秒前
XJC完成签到,获得积分10
8秒前
周游普列国完成签到 ,获得积分10
8秒前
皮皮发布了新的文献求助10
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180339
求助须知:如何正确求助?哪些是违规求助? 9570391
关于积分的说明 21811279
捐赠科研通 7776418
什么是DOI,文献DOI怎么找? 3433277
关于科研通互助平台的介绍 2557483
邀请新用户注册赠送积分活动 2479091